Notably, Interleukin 2 (IL-2) signaling has been implicated in CC progression, with research suggesting that IL-2 not only promotes tumor cell proliferation but also modulates the immune microenvironment, contributing to tumor growth and immune evasion (Gutiérrez-Hoya et al. 2024). This evidence concerns the gene IL2 and neoplasm.